You are here


Research Catalyst Network: Rare Diseases

Thursday, October 17, 2013

The goal of the “Research Catalyst Network: Expediting collaboration between basic and clinician scientists in functional studies of novel rare disease genes” is to establish a national consortium that will enable clinical geneticists who are identifying rare disease gene mutations to collaborate with model organism researchers with expertise in the cognate gene’s function.

Capitalizing On Big Data: Agencies launch consultation on digital scholarship

Wednesday, October 16, 2013

Canada’s federal research granting agencies—the Social Sciences and Humanities Research Council (SSHRC), the Natural Sciences and Engineering Research Council (NSERC), the Canadian Institutes of Health Research (CIHR), as well as the Canada Foundation for Innovation (CFI), and in collaboration with Genome Canada—have joined forces to help address digital infrastructure challenges through the consultation document 

New Discoveries for Cancer Risk: Researchers Worldwide Take Part in one of History’s Largest Scientific Consortium

Wednesday, October 9, 2013

Hundreds of researchers from North America, Europe, Australia and Asia have joined together in a consortium to identify the genetic basis of the five most common forms of cancer – breast, prostate, lung, ovarian and colorectal. The group, called the OncoArray Consortium, developed a new customized genotyping tool – the OncoArray – manufactured by the U.S. genomics firm Illumina, Inc.

Ontario Genomics Institute Launches Scintelligence, a New Division to Help Industry Tap into the Power of Life Science Solutions

Tuesday, September 24, 2013

The Ontario Genomics Institute (OGI) today announced the launch of Scintelligence, a new industry-focused division to help companies in a variety of sectors capitalize on research and innovation in the life sciences. This division will engage the private sector to identify challenges and business needs, and facilitate collaborations between partners in industry, academia and government.